226 related articles for article (PubMed ID: 28768142)
41. Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: a meta-analysis of 33 case-control studies.
Dai YE; Tang L; Healy J; Sinnett D
PLoS One; 2014; 9(11):e113748. PubMed ID: 25423013
[TBL] [Abstract][Full Text] [Related]
42. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
[TBL] [Abstract][Full Text] [Related]
43. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.
Chokkalingam AP; Hsu LI; Metayer C; Hansen HM; Month SR; Barcellos LF; Wiemels JL; Buffler PA
Cancer Causes Control; 2013 Oct; 24(10):1789-95. PubMed ID: 23836053
[TBL] [Abstract][Full Text] [Related]
44. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
[TBL] [Abstract][Full Text] [Related]
45. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
46. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
47. High frequency of the risk allele of rs4132601 and rs11978267 from the IKZF1 gene in indigenous Mexican population.
Gutiérrez-Franco J; Ayón-Pérez MF; Durán-Avelar MJ; Vibanco-Pérez N; Sánchez-Jasso DE; Bañuelos-Aguayo DG; Sánchez-Meza J; Pimentel-Gutiérrez HJ; Zambrano-Zaragoza JF; Agraz-Cibrián JM; Vázquez-Reyes A
Mol Genet Genomic Med; 2021 Feb; 9(2):e1589. PubMed ID: 33452870
[TBL] [Abstract][Full Text] [Related]
48. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
Zhou X; Liao F; Zhang J; Qin Y; Xu H; Ding Z; Zhang Y; Zhang F
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654170
[TBL] [Abstract][Full Text] [Related]
49. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
50. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea.
Han S; Lee KM; Park SK; Lee JE; Ahn HS; Shin HY; Kang HJ; Koo HH; Seo JJ; Choi JE; Ahn YO; Kang D
Leuk Res; 2010 Oct; 34(10):1271-4. PubMed ID: 20189245
[TBL] [Abstract][Full Text] [Related]
51. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.
Lautner-Csorba O; Gézsi A; Semsei AF; Antal P; Erdélyi DJ; Schermann G; Kutszegi N; Csordás K; Hegyi M; Kovács G; Falus A; Szalai C
BMC Med Genomics; 2012 Sep; 5():42. PubMed ID: 23021489
[TBL] [Abstract][Full Text] [Related]
52. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
[No Abstract] [Full Text] [Related]
53. Inherited susceptibility to pediatric acute lymphoblastic leukemia.
Levine RL
Nat Genet; 2009 Sep; 41(9):957-8. PubMed ID: 19710713
[TBL] [Abstract][Full Text] [Related]
54. Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia.
Aref S; El-Ghonemy M; Shimaa H; Darwish A; Abdelmabood S; Khaled N
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e334-e338. PubMed ID: 36897378
[TBL] [Abstract][Full Text] [Related]
55. Association of CDKAL1, CDKN2A/B & HHEX gene polymorphisms with type 2 diabetes mellitus in the population of Hyderabad, India.
Kommoju UJ; Samy SK; Maruda J; Irgam K; Kotla JP; Velaga L; Reddy BM
Indian J Med Res; 2016 Apr; 143(4):455-63. PubMed ID: 27377502
[TBL] [Abstract][Full Text] [Related]
56. A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children.
de Smith AJ; Wahlster L; Jeon S; Kachuri L; Black S; Langie J; Cato LD; Nakatsuka N; Chan TF; Xia G; Mazumder S; Yang W; Gazal S; Eng C; Hu D; Burchard EG; Ziv E; Metayer C; Mancuso N; Yang JJ; Ma X; Wiemels JL; Yu F; Chiang CWK; Sankaran VG
Cell Genom; 2024 Apr; 4(4):100526. PubMed ID: 38537633
[TBL] [Abstract][Full Text] [Related]
57. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations.
Zhang H; Mao JS; Hu WF
Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116
[TBL] [Abstract][Full Text] [Related]
58. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
[TBL] [Abstract][Full Text] [Related]
59. An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes.
Swafford AD; Howson JM; Davison LJ; Wallace C; Smyth DJ; Schuilenburg H; Maisuria-Armer M; Mistry T; Lenardo MJ; Todd JA
Diabetes; 2011 Mar; 60(3):1041-4. PubMed ID: 21270240
[TBL] [Abstract][Full Text] [Related]
60. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
